BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
BROS
Dutch Bros Inc.
BROS has the edge over BABA overall, supported by stronger valuation and stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
BROS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BROS's revenue, profitability, cash flow and balance sheet are all currently healthy.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
BROS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $33.71 | — |
| Current | 43x | $33.71 | — |
| Cheap | 88x | $68.51 | +103% |
| Fair | 162x | $126 | +275% |
| Expensive | 567x | $442 | +1213% |
Historical ranges are pointers, not guarantees.
BROS has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over BROS on the outlook, with more favorable profitability expectations.
BROS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BROS, with profitability holding steady. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
BROS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.10 | +41% |
| Q3 2026 | $0.78 | +56% |
| Q2 2026 | $0.72 | +53% |
| Q1 2026 | $0.64 | +64% |
| Q4 2025 | $0.64 | +88% |
| Q3 2025 | $0.50 | +72% |
| Q2 2025 | $0.47 | +88% |
| Q1 2025 | $0.39 | +117% |
| Q4 2024 | $0.34 | +1033% |
BROS has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
BROS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $549.8M | +30% |
| Q2 2026 | $550.9M | +32% |
| Q1 2026 | $464.4M | +31% |
| Q4 2025 | $443.6M | +29% |
| Q3 2025 | $423.6M | +25% |
| Q2 2025 | $415.8M | +28% |
| Q1 2025 | $355.2M | +29% |
| Q4 2024 | $342.8M | +35% |
BROS has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.6% | -0.2 points |
| Q2 2026 | 13% | -0.4 points |
| Q1 2026 | 7.4% | -1.4 points |
| Q4 2025 | 7.7% | +3.1 points |
| Q3 2025 | 9.8% | +0.2 points |
| Q2 2025 | 13% | +3.2 points |
| Q1 2025 | 8.8% | -0.6 points |
| Q4 2024 | 4.6% | +3.7 points |
BROS has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
BROS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.8M | -22% |
| Q2 2026 | $39.9M | +12% |
| Q1 2026 | $27.7M | +$36.4M |
| Q4 2025 | $8.5M | -56% |
| Q3 2025 | $18.9M | -28% |
| Q2 2025 | $35.7M | +$40.6M |
| Q1 2025 | -$8.7M | +$7.6M |
| Q4 2024 | $19.5M | +$35.2M |
BROS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over BROS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
BROS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +3.4M shares |
| 1 year | +8.5% | +10.8M shares |
| 3 years | +141% | +80.8M shares |
| 5 years | +195% | +91.4M shares |
| Available history | +181% | +89.1M shares |
BROS has 138M diluted shares, up 8.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
BROS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
BROS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
BROS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 8.2 | Oversold |
BROS's weekly RSI is 31 (neutral) and its Stochastic is 8 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over BROS on valuation relative to its sector.
BROS PE vs Consumer Cyclical Sector
| Metric | BROS | Sector median | Relative |
|---|---|---|---|
| PE | 43x | 18x | 140% above |
| PE % | 0 | 57 | 57 pts below |
BROS is trading at 43x earnings, a 140% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
BROS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 12% below |
| 20 week MA | $49.0 | 31% below |
| 50 week MA | $53.8 | 37% below |
| 100 week MA | $58.1 | 42% below |
| 200 week MA | $45.3 | 26% below |
BROS is in a downtrend: it's below all five of its weekly moving averages, and 26% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over BROS on returns for 2026, with the stronger performance.
BROS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $43.6 | $52.9 | +21% |
| 2022 | $52.9 | $30.1 | -43% |
| 2023 | $30.1 | $31.7 | +5.3% |
| 2024 | $31.7 | $53.4 | +68% |
| 2025 | $53.4 | $64.0 | +20% |
| 2026 YTD | $64.0 | $33.7 | -47% |
BROS is down 47% so far in 2026, after finishing higher in four of the previous five years.